Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4
The primary endpoint, the between-group change in left ventricular mass, demonstrated that tirzepatide significantly reduced left ventricular mass and paracardiac adipose tissue compared to placebo, with reductions in weight loss
Octreotide: a therapeutic option for idiopathic intracranial hypertension
The assessment of DNA damage using markers like cyclobutene pyrimidine dimers, and the analysis of barrier proteins filaggrin and loricrin, provided insights into how glutathione amino acid precursors may shield the skin from UV-related harm
2023;108(9):e83241
US$ 25.74
US$ 21.86
US$ 21.98
US$ 22.34
US$ 24.75
US$ 26.25
